In a relatively quiet month for price rises among typical generics in the UK, four presentations of the same molecule – epilepsy drug lamotrigine – topped our table of Biggest Risers in October, based on the latest figures from market researcher WaveData which monitors trade prices to UK independent pharmacists.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?